| Friday, November 4, 2022 10:25-16:00 Central European Time (CET) |
|
| 10:25 | Welcome Note Yuval Yaron, Israel |
| 10:30-11:00 | Clinical use cases of Prenatal Genome Sequencing Sponsored symposium- Illumina |
| 10:30-10:45 | From prenatal exome sequencing to prenatal genome sequencing: takeaways from >1500 cases Peter Bauer, Centogene, Germany |
| 10:45-11:00 | Clinical application of prenatal WGS with an in silico gene panel for detecting genetic causes to non-immune hydrops fetalis Eini Westenius, Sweden |
| 11:00-12:30 | Session 1: Advances in Prenatal Diagnosis |
| 11:00-11:30 | Prenatal ES for the investigation of congenital malformations: the UK experience Mark Kilby, UK |
| 11:30-12:00 | Prenatal exome and genome sequencing in pregnancy Neeta Vora, USA |
| 12:00-12:30 | Genetics of fetal growth restriction Toni Borrell, Catalunya |
| 12:30-13:30 | Developments in Rolling Circle Amplification for Prenatal Screening Sponsored symposium- Perkin Elmer |
| Introduction Tarja Ahola, Finland |
|
| Screening for main aneuploidies with Rolling Circle Amplification in twin pregnancies Alexandre Vivanti, France |
|
| Evaluation of a simplified cfDNA screening method for common autosomal trisomies: Issues and updates Geralyn Lambert-Messerlian, USA |
|
| Prenatal screening performance of the RCA methodology Glenn E. Palomaki, USA |
|
| Live Q&A Session Alexandre Vivanti, France Geralyn Lambert-Messerlian, USA Glenn E. Palomaki, USA Olof Karlberg, Sweden |
|
| 13:30-16:00 | Session 2: Non-Invasive Prenatal testing |
| 13:30-14:00 | CLIA lab experience with a non-invasive cell-based prenatal genetic test Art Beaudet, LunaGenetics, USA |
| 14:00-14:30 | Cell-based NIPT: a new approach for prenatal testing Francesca Romana Grati, Menarini Biomarkers, Italy |
| 14:30-15:00 | Cell based NIPT – Special focus on screening for cystic fibrosis by detecting the 50 most common variants in the CFTR gene Line Dahl Jeppesen, ARCEDI, Denmark |
| 15:00-15:30 | cfDNA testing: the more the better? Liona Poon, Hong Kong |
| 15:30-16:00 | The NIPT model implemented in England Pranav P Pandya, UK |
| Saturday, November 5, 2022 10:30-14:30 Central European Time (CET) |
|
| 10:30-11:30 | A CE-marked IVDD Preimplantation Genetic Analysis Solution of Aneuploidies in Embryos Sponsored symposium- Thermo Fisher Scientific Alain Rico, Sr. Manager, Market capital Development, Thermo Fisher Scientific, France |
|
|
| 11:30-14:30 | Session 3: Preimplantation genetic testing (PGT) Moderator: Avner Hershlag, USA |
| 11:30-12:00 | The developmental and chromosomal landscape of human embryonic arrest Christian Ottolini, UK |
| 12:00-12:30 | Is PGT always right? Tony Gordon, UK |
| 12:30-13:00 | Cell-free PGTa – better genomic accuracy? Svetlana Madjunkova, Canada |
| 13:00-13:30 | PGT for ‘de novo’ aberrations Martine De Rycke, Belgium |
| 13:30-14:00 | Misconceptions of polygenic risk scoring for embryo selection (PGTP) Nathan Treff, USA |
| 14:00-14:30 | Congress summary and Highlights Yuval Yaron, Israel |